SARS-CoV-2 mRNA vaccination induces an immune response in the nasal mucosa, study finds

FHS
June 28, 2023
11:18 am

Respiratory viruses are known for their ability to enter the body through the eyes, nose, or mouth. Our bodies know that, too.

LIB details Ph3 PCSK9 inhibitor data; Eyenovia seeks ‘strategic alternatives’

Plus, news about Inozyme and Sensorion: LIB Therapeutics touts positive Phase 3 cholesterol results: The company’s third-generation PCSK9 inhibitor, lerodalcibep, achieved a 56% LDL-C reduction

April 9, 2024

Elevated TMAO levels linked to higher diabetes risk, study finds

A recent Nutrients study links elevated trimethylamine N-oxide (TMAO) levels with an increased risk of type 2 diabetes, highlighting the role of diet in diabetes

June 5, 2024

Newborn Hep B Vax Refusal Rates Dropped During Pandemic, D.C. Study Finds

Fewer mothers in Washington, D.C., refused to have their newborns receive an initial birth dose of the hepatitis B vaccine (Engerix-B, Recombivax HB) in recent

July 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.